BofA raises CenterPoint Energy stock price target to $44 on valuation

BofA Securities raised CenterPoint Energy’s price target to $44 from $42 while keeping a Neutral rating, with analyst Ross Fowler reiterating the stance. The firm held its 2026 and 2028 EPS estimates at $1.91 and $2.27, respectively, and nudged 2027 EPS to $2.08 from $2.09. CenterPoint also highlighted $1.19 billion of system restoration bonds and $600 million of 2.875% convertible notes due 2029, while maintaining a 2.14% dividend yield and 56 straight years of dividend payments.

Analysis

The market is treating this as a low-conviction utility rerate, but the real signal is balance-sheet engineering. Management is effectively monetizing rate-base visibility and storm-restoration assets at a time when credit investors are still willing to underwrite long-duration cash flows, which reduces equity dilution risk and supports the multiple even if near-term EPS growth stays mechanical rather than organic. The raise in target looks less like a fundamental re-rating and more like confirmation that the bond market is temporarily subsidizing equity stability.

The second-order effect is that CNP’s financing mix can become a self-reinforcing story: cheaper secured funding for restoration and convertible issuance lowers equity capital intensity, but it also caps upside because the stock starts to trade like a quasi-credit instrument rather than a true growth utility. That matters if rates stay sticky or utility spreads widen; in that regime, the stock’s current valuation becomes fragile because investors will demand either faster EPS delivery or a higher allowed return regime to justify the premium.

The contrarian read is that consensus is underpricing the downside asymmetry from execution slippage. When a utility is priced close to its highs while guidance is already framed around mid-to-high end achievement, there is little room for missed capex timing, storm-related regulatory friction, or a turn in the credit window. The setup is more attractive for harvesting premium than for chasing upside: the next leg higher likely requires a catalyst in regulation or rates, not just another incremental analyst target bump.

Key Decisions for Investors

• Sell upside call spreads in CNP into strength over the next 1-2 months; the stock is already near full valuation for its growth profile, and premium capture is preferable to outright long exposure.
• For income-oriented exposure, prefer a pair trade: long CNP / short a lower-quality regulated utility with weaker balance sheet metrics over 3-6 months, since CNP’s access to secured funding should compress financing risk relative to peers.
• If holding CNP long-term, hedge with out-of-the-money puts into any rate-backed rally; the stock’s upside is capped by valuation, but downside can reprice quickly if utility spreads widen.
• Avoid initiating fresh outright longs above the current trading range unless there is evidence of accelerated EPS beats or a constructive move in real rates; risk/reward is skewed to flat-to-down over 1-3 months.